Geographic Atrophy Clinical Trials

Geographic atrophy clinical trials test ways to slow the loss of retinal cells, most often by calming an overactive part of the immune system called the complement pathway. Some trials study people in the earlier stages of the disease to see whether starting treatment sooner preserves more vision over time.

Until 2023, there was no approved treatment that targeted geographic atrophy directly, only supplements aimed at slowing progression toward it. The two treatments approved that year target the same immune pathway from slightly different angles, and neither restores vision already lost. Ongoing trials are how researchers are working toward earlier intervention and, eventually, real vision recovery.

Eligibility usually depends on how much of the retina is affected and which eye or eyes have geographic atrophy, since lesion size and location shape what a study can measure. Some trials focus on people who are newly diagnosed, while others look for those whose atrophy has continued to grow despite treatment. Eligibility always varies by study.

Trials generally fall into a few groups. Some test complement inhibitor injections similar to the two already approved, others test entirely different mechanisms aimed at protecting retinal cells directly, and some are gene therapy approaches designed to reduce how often injections are needed. A smaller group focuses on better ways to detect and measure the disease earlier.

Geographic atrophy is a specific, advanced stage of macular degeneration, specifically the dry form. Not everyone with macular degeneration develops geographic atrophy, and the wet form of macular degeneration is a different process involving abnormal blood vessel growth rather than gradual cell loss.

Yes, especially early on. Vision changes can overlap with diabetic retinopathy or glaucoma, particularly in older adults who may have more than one eye condition at once. A dilated eye exam and retinal imaging are what actually distinguish between them.

Every study is reviewed by an independent ethics board before it can enroll anyone, and the specific risks, since most current treatments involve regular eye injections, are explained to you during informed consent, before you agree to anything.

Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.

Clinical Trial Benefits, Risks & Safety Considerations

Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.

Curious whether clinical trials pay participants? Here's how compensation actually works.

How Much do Clinical Trials Pay? Everything You Need to Know About Getting Paid For Clinical Trials